Clinical Trial Shows Synthetic Cannabis Reduces Agitation in Alzheimer’s Disease

In a study led by the Johns Hopkins University School of Medicine and Tufts University School of Medicine, researchers show that a pill form of the drug dronabinol, an FDA-approved synthetic version of marijuana’s main ingredient, THC, reduces agitation in patients with Alzheimer’s by an average of 30%.

Cannabis Exposure during Pregnancy Had Sex-dependent Effects on Rats’ Breathing in Adult Offspring

Article title: Long-term effects on cardiorespiratory and behavioral responses in male and female rats prenatally exposed to cannabinoid Authors: Luis Gustavo A. Patrone, Alana T. Frias, Gabriel T. Fantinatti, Angelita M. Stabile, Wilfried Klein, Kênia C. Bicego, Luciane H. Gargaglioni From the…

Toxic metal particles can be present in cannabis vapes even before the first use

Vapes are thought to be a “safer” way to consume cannabis, but they present their own risks. Researchers have discovered toxic metal particles in vaping liquids even before first use of the device, and this toxicity was worse in illicit products. They will present their results at ACS Spring 2024.

High school students who report using alcohol, cannabis or nicotine at higher risk for suicidal thoughts and other mental health disorders

High school students who reported using cannabis, alcohol, or nicotine were more likely to have thoughts about suicide, feel depressed or anxious, have unusual experiences, and exhibit inattention or hyperactivity, according to recent survey-based study conducted by researchers at Massachusetts General Hospital (MGH) and the University of Minnesota.

Concurrent use of alcohol and cannabis leads to higher levels of drinking in the longer term

Co-existing use of alcohol and cannabis can lead to negative outcomes such as the development of a substance-use disorder, poor academic and occupational performance, and psychiatric disorders when compared to use of either drug alone. New research that examines simultaneous alcohol/cannabis use has found higher levels of drinking after 18 months. These results and others will be shared at the 46th annual scientific meeting of the Research Society on Alcohol (RSA) in Bellevue, Washington.

Cannabis use disorder and schizophrenia connection: expert says the drug, “seems to be amplifying some of the consequences that we are seeing”

What: A new study in Psychological Medicine found an association between young men with cannabis use disorder and a higher risk of developing schizophrenia. Furthermore, intense cannabis use may trigger and/or worsen schizophrenia.  Who: Katharine Sperandio, Ph.D., LPC, ACS, NCC, assistant professor of…

Research Reveals THC Concentration in Colorado Retail Cannabis Products is Lower than Advertised

While legal cannabis products in the United States are required to report THC potency levels on their packaging those levels aren’t necessarily accurate, which can have important implications for cannabis consumers. According to a new study from the University of Northern Colorado’s Department of Biological Sciences, researchers Mitchell McGlaughlin and Anna Schwabe found that the THC potency values reported on the packaging of cannabis samples from dispensaries across Colorado’s Front Range are substantially over-reported.

Multiple substance use disorders may share inherited genetic signature

New research led by Washington University School of Medicine in St. Louis identifies a common genetic signature that may increase a person’s risk of developing substance use disorders. The work eventually could lead to universal therapies to treat multiple substance use disorders and potentially help people diagnosed with more than one.

Cannabis use in adolescent years may create reproductive complications in women, according to a UC Irvine study

In a new study, University of California, Irvine researchers found that exposure to the compound tetrahydrocannabinol (THC), a component of cannabis, at a young age could lead to depleted ovarian follicles and matured eggs in adulthood by nearly 50 percent.

First-of-its-Kind Study Examines the Impact of Cannabis Use on Surgical Patients’ Post-Procedure Healthcare Needs

In patients who underwent non-cardiac surgery in Boston between 2008 and 2020, those with a diagnosed cannabis use disorder more often required advanced postprocedural healthcare compared to non-users. However, patients whose use of cannabis was not classified as a disorder had lower odds of requiring advanced healthcare after surgery compared to patients who never use cannabis.

Study First to Show Statewide Cannabis-related Deaths in Florida

There has been a 1,107.01 percent increase in the number of people with medical cannabis cards in Florida (2018 to Jan. 27). One key reason is because many people believe cannabinoids – plant derived, medicinal, and synthetic or chemically engineered – are safe to use. A study shows that 386 people died in Florida as a result of cannabis use; of these, 258 cases were caused by synthetic cannabis. Nearly 88 percent were men; 28 percent of deaths were in those ages 45 to 54, compared to 9 percent in those ages 8 to 24. Nearly 99 percent of individuals using cannabis and synthetic cannabis died from accidents.

All Patients Should be Screened for Cannabis Use Before Surgery, First U.S. Guidelines Recommend

All patients undergoing procedures requiring anesthesia should be asked about cannabis use, according to guidelines released by the American Society of Regional Anesthesia and Pain Medicine (ASRA Pain Medicine). The first U.S. guidelines on cannabis use in relation to surgery also notes regular use may worsen pain and nausea after surgery and increase the need for opioids.